wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28742444-3750712F-3FDD-4A0E-8C5F-A5A056D5A8E3
Q28742444-3750712F-3FDD-4A0E-8C5F-A5A056D5A8E3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28742444-3750712F-3FDD-4A0E-8C5F-A5A056D5A8E3
Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach
P2860
Q28742444-3750712F-3FDD-4A0E-8C5F-A5A056D5A8E3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28742444-3750712F-3FDD-4A0E-8C5F-A5A056D5A8E3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d9991f1e96092efef4239c295269a9caf258ceb3
P2860
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.